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New Methods for Detection
of Low Levels of DNA Damage
in Human Populations
by William A. Haseltine,*t* William Franklin*
and Judith A. Lippket
The use ofapostlabeling method tocharacterize and todetect infrequent base modifications in
DNA is outlined. This method has the advantage that low levels of DNA modifications,
approximately 1 modified base per 105 nucleotides, can be detected. Moreover, a broad spectrum
of modification can be identified by using this methodology. The basis for the method involves
transfer of a radioactive phosphate from the y position of ATP to the 5'-hydroxyl terminus of
3'-phosphoryl nucleotides that arederived from modified DNAby appropriate nuclease digestion.
The second method involves use ofadefined DNAsequence within human cells. The a sequence is
used as a probe for DNA damage to specific nucleotides. The a DNA sequence is reiterated
approximately 300,000 times in the human genome and exists in tandem arrays. It comprises
approximately 1% ofthe entire genome. The reiterated sequence is sufficiently homogeneous to
permit its use as a probe for a site specific in DNA damage.
Examples ofthe application ofboth ofthese methodologies to DNAdamage inflicted in human
cells by chemicals and ultraviolet light are provided.
Introduction
Exposure ofhumans to toxic substances poses an
increasing health riskthroughout the industrialized
world. Measurement of the health risk associated
with such exposure is bedeviled by a myriad of
problems. Problems begin with the accurate assess-
ment of exposure. Exposures often occur over long
periods oftime to low levels ofcomplex mixtures of
chemical substances. Compounding the complexity
of the problem is the likelihood that individuals
respond differently to different sets of substances.
Differences in individual health and metabolism
maydramaticallyaltertheaffectofa given exposure.
What tools must be developed to grapple with
this intractable problem? Accurate means for
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individual dosimetry are needed. Methods for
assessment of biological damage to individuals are
necessary. Means for determination ofwhich chemi-
cal, amongavariety ofchemical exposures, leadsto
observable biological changes must be developed.
Over the past few years, we have developed
several new techniques that meet some of these
needs. The methods were designed to provide
insights into mechanisms of DNA damage and
repair. Applied to the area of human toxicology,
they should provide sensitive, analytical tools for
determination ofindividual loads of DNA damage.
Postlabeling Methods to Detect
and Characterize Infrequent Base
Modifications in DNA
We sought to develop a method for the detection
of DNA lesions that could measure low levels of
damage in DNA of exposed individuals. The
postlabeling method described below has the fol-
lowing attractive features for such work.HASELTINE, FRANKLIN AND LIPPKE
Low levels of DNA modifications can be detect-
ed. The limit of sensitivity is probably about one
modified base per 105.
A broad spectrum ofmodifications can be detect-
ed. Both small and large base adducts can be
detected. Alterations in sugars and in the bases can
also be resolved. Intrastrand and interstrand cross-
links can be detected as well.
The specific type of damage can be determined.
Each DNA modification can be analyzed indepen-
dently. The contribution to DNA damage of each
component of a complex mixture can be identified.
Consequently, the damage created by specific envi-
ronments should yield a characteristic "fingerprint"
of lesions. Such fingerprint analysis could permit
tracing of DNA damage to particular types oftoxic
waste, and permit cause-effect relationships to be
established.
The persistence of each type of lesion can be
measured. Measurements taken over time would
permitanalysisofthepersistence ofspecific lesions.
The method would provide an individual dosime-
terofeffective exposure. Measurement ofexposure
based on ambient levels ofa substance in the air or
water do not measure accurately individual expo-
sure. Measurement of serum and urine levels of
substances do measure individual burdens. Howev-
er, the biological affects ofagiven level ofexposure
may vary considerably from person to person.
Measurement ofthe level of DNA damage is likely
to provide abetterindicator ofthe biological effects
of exposure than other methods.
The measurements can be performed on very
small tissue samples. A 1- or2-,ug quantity ofDNA
is all that is required for complete analysis. Such
amounts of DNA can be collected from routine
blood samples or from microbiopsy samples.
The Method
A new method is presented that allows the detec-
tion and characterization of infrequent base modi-
fications in DNA. The method combines the tech-
nique of in vitro labeling of nucleotides derived
from cellular DNA with the methods of high pres-
sure liquid chromatography (HPLC). Previous meth-
ods forthe detection ofmodified bases in DNA have
included the use of radioactive drugs or modifying
agents (1) and the uniform labeling of DNA by
feedingcellsradioactiveDNAprecursors. Themethod
presented here differs fromtheseprevious methods
as DNA is postlabeled after being treated with a
DNA base-modifying agent.
An example of the DNA postlabeling method is
demonstrated. DNA was treated in vitro with
dimethyl sulfate (DMS), a DNA alkylating agent.
DMS reacts with purines in DNA (2), the principal
adducts formed being 7-methylguanine, 3-methyl-
adenine and 1-methyladenine (3). Following DMS
treatment, the DNA was isolated, and digested to
nucleotides. The nucleotides were then postlabeled
andwereresolvedbyHPLC. DMS-methylatedbases,
in nucleotide form, were readily resolved from the
four normal DNA bases and were detected along
with two other minor products, 5-methylcytosine
and uracil.
DNA Postlabeling Procedure
The basic procedure for postlabeling DNA is
presented in Figure 1. DNA is modified with a
DNA damaging agent that produces stable base
modifications. The modified DNA is isolated and is
digested by two enzymes, micrococcal nuclease and
spleenphosphodiesterase, tofonn3'-deoxynucleoside
monophosphates (4). The 3'-nucleotides are then
labeled with 32P at the 5' position by the addition of
highspecificactivity y32PATPandT4polynucleotide
kinase (5). A mutant enzyme that lacks the endoge-
nous 3'-phosphatase activity (6) is used to label the
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FIGURE 1. Outline of the DNA postlabeling method.
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nucleotides, theproductsproducedbeing3'5'-deoxy-
nucleoside diphosphates. The 3'-phosphate group is
then removed by the addition of normal T4 poly-
nucleotidekinasewhichcontains3'-phosphatase activ-
ity (7). ThenormalfourDNAnucleotides arelabeled,
as are any nucleotides containing modified bases.
Materials and Methods
Reagents and Buffers
Used were DMS, 1.22 g/L (Aldrich); 3M Na ace-
tate, pH 5.5; ethanol; 0.1MCaCl2; 0.1MTris-Cl, pH
7.5; 0.05M Tris-Cl, pH 7.5; 0.1M HCI. The post-
labeling reaction buffer was 16 mM MgCl2. Also
usedwere8mMdithiothreitol(DTT), 50mMTris-Cl,
pH 7.4, 200 ,ug/mL bovine serum albumin (Sigma)
and y3 P 5'-ATP (New England Nuclear, 1.7 FM,
3.94mCi/mL, 3100 Ci/mmole). The deoxynucleotides
-5'-dCMP, 5'-dUMP, 5'-methyl-5'-dCMP, 5'-dTMP,
5'-dGMP and 5'-dAMP (Sigma) -were used at con-
centrations of 0.5 mg/mL ofeach in 50mM Tris-Cl,
pH 7.4.
DNA
DNAwas extracted fromahumanlymphoblastoid
cell line, TK6 (8), using a standard phenol/chloro-
form-isoamylalcoholmethod aspreviouslydescribed
(9). The DNA was freed ofRNA by treatment with
RNAse A. DNA at a concentration of 450 ,ug/mL
was stored in lOmM Tris-Cl, pH 7.4, lmM EDTA
at 40C.
Enzymes
DNAse I was used at 50 mg/mL (Sigma, 640
unitsmg) in lOmM Tris-Cl, pH 8.5, and lOmM
CaC12. It was stored at 40C.
Snake venom phosphodiesterase, 100 units/mL
(Worthington) in lOmMTris-Cl, pH 10.4, and 50mM
CaCl2, micrococcal nuclease, 100 units/,uL (Worth-
ington)and spleen phosphodiesterase, 32 units/mL
(Sigma) were also stored at 4°C. T4 polynucleotide
kinase (no 3'-phosphatase activity), 6000 units/mL
(New England Nuclear) in lOmM Tris-Cl, pH 7.5,
lmM DTT, 50mMKCl, 0.lmM EDTA, 0.1,uM ATP
and 50% glycerol (v/v) was purified fromT4PseTiam
E10-infected E. coli (6). It was stored at -20°C. T4
polynucleotide kinase (containing 3'-phosphatase
activity) was used at 1500 units/mL (New England
Biolabs) in 50mM KCI, lOmM Tris-Cl, pH 7.4,
0.lmM EDTA, lmM DTT, 200 ,ug/mL BSA, 50%
glycerol (v/v). It was stored at -20°C.
Reaction of DMS with DNA
DNA was made up at a concentration of 400
,ug/mL in lOOmMTris-Cl, pH 7.5. DMS (20 FL) was
reacted with 180 ,uL of DNA for 1.5 hr at 37°C. As
a control, 20 puL of lOOmM Tris-Cl, pH 7.5, was
added to 180 pL ofDNA and was also incubated at
37°C for 1.5 hr. Following the incubation, 22 ,uL of
3M Na acetate, pH 5.5, and 450 ,uL ofethanol were
added to the incubation mixture to precipitate the
DNA. The tube was well mixed and placed in a dry
ice/ethanol bath at -70°C for 10 min and was then
centrifuged at 12000g for 10 min. The supernatant
was removed and the DNA pellet was washed with
200 pL of ethanol and centrifuged at 12000g,for 5
min. The supernatant was removed and the DNA
was lyophilized.
DNA Digestions
5'-Digestion. Lyophilized DNA(72 ,ug)wasreacted
with 40 pL of DNAse I and 20 ,uL of snake venom
phosphodiesterase. The DNA was incubated with
the enzyme mixture overnight at 37°C.
3'-Digestion. Lyophilized DNA (72 ,ug) was incu-
bated with 2 pL1 of0.1M CaClz, 5,iL ofmicrococcal
nuclease, 20 ,LL of spleen phosphodiesterase, and
33 ,LL of 50 mM Tris-Cl, pH 7.4. The DNA was
digested for 1 hr at 37°C.
5'-Labeling of 3'-Deoxynucleotides
The mixture of 3'-digested DNA was diluted
1:500 to an approximate concentration of 1O,uM
3'deoxynucleotides. The3'-deoxynucleotides(5pL=
50pmole) werereactedwith2 ,LofT4polynucleotide
kinase (New England Nuclear, no 3' phosphatase
activity), 20 ,uL of y32P ATP, and 49 FL of the
postlabeling reaction buffer at 37°C for 2 hr. Sub-
sequently, 4 pL of O.lM HCI was added to adjust
the pH to 6.0 and 10 pL1 ofT4 polynucleotide kinase
(New England Biolabs, containing 3'-phosphatase
activity) was added, and the reaction was incubated
for an additional 2 hr at 37°C.
In order to remove any unreacted _y32P ATP, the
labeled nucleotides were separated from ATP by
the use ofa Bond-Elut mini-extraction column con-
taining 100 mg of an aminopropyl sorbent (Analy-
tichem. International, Harbor City, CA). The col-
umn packing material consists ofaminopropyl moi-
eties bonded to silica. The reaction mixture of
5'-labeled nucleotides (90 p,L) was added to the top
of the column, along with 500 puL of water. The
column, whichcontainsthesorbentin a1-cm3syringe,
was placed in a 15 mL centrifuge tube and was
centrifuged for 3 min at 5000 rpm in a clinical
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centrifuge. The elutant was discarded, and 500 ,L
of 0.1M KH2PO4, pH 4.5, was added to the top of
the column to elute the 5'-labeled nucleotides. The
column was againplaced in a 15 mL centrifuge tube
and was centrifuged at 5000 rpm for 3 min. The
elutant was collected and lyophilized. The radioac-
tive 5'-nucleotides were resuspended in 200 ,uL of
water.
HPLC Instrumentation and Separation
Procedures
HPLC instrumentation included a Varian 5020
liquid chromatograph equipped with a Valco loop
injector fitted with a 50 ,uL sample loop. Additional
equipment included a Varian UV-50 variable wave-
length detector and an ISCO model 328 fraction
collector equipped with a stop-flow valve.
Separation of5'-deoxynucleotides wasperformed
on a Waters Bondapak C18 reverse phase column
(300 x 4mm). A gradient elution was utilized in
which aninitial elutionbufferconcentration of100%
75mM KH2PO4, pH 4.5, wasmaintained for 15min,
followed by a linear gradient for 15 min to a final
elutionmixtureof40%methanol, 60%75mMKH2PO4,
pH 4.5. The flow rate was maintained at 1 mL/min.
UV detection of5'-deoxynucleotides was at awave-
length of 260 nm.
For radioactivity measurements, fractions were
obtained ofliquid eluting from the column at inter-
vals of0.3 min each. Fractions were collected in 1.5
mL micro test tubes (Eppendorff). The 32P radioac-
tivityineachfractionwasdeterminedbyCerenekov
countingusingaBecknan LS8000scintillation count-
er.
Example of Postlabeling Method
DMS Modification of DNA
To demonstrate the DNA postlabeling method,
human DNA was treated in vitro with DMS to
allowsufficientalkylationofpurinebases. The DNA
wasthendigestedtoboth3'-and5'-deoxynucleoside
monophosphates. The3'-deoxynucleotideswerethen
postlabeled with 32P and were subjected to the
3'-phosphatase activityofT4polynucleotidekinase,
forming 5'-labeled deoxynucleotides. This step is
included in the labeling procedure as there is much
more selectivity in the separation of nucleoside
monophosphates than nucleoside diphosphates by
HPLC. The 5'-deoxynucleotides formed from the
digestion of DNA by DNAse I and snake venom
phosphodiesterase are used asmarkersforthe radio-
active nucleotides.
The use of reverse-phase chromatography as a
highly selective method for the separation ofnucle-
otides is demonstrated in Figure 2. In this separa-
tion, the four common deoxynucleotides 5'-dCMP,
5'-dTMP, 5'-dGMP and 5'-dAMP are readily sepa-
rated and resolved, as are two nucleotides contain-
ing bases less frequently found in DNA-5'-dUMP
and5'-methyl-5'-dCMP. Theoccurrenceof5'-dUMP
is found in DNA as a result of the deamination of
cytosine. Theoccurrence of5-methylcytosine results
from methylation of cytosine and represents about
0.4% ofthe total bases in DNA of HeLa cells (10).
Theseparationof5'-deoxynucleotidesfromdigested
human DNA is shown in Figure 3.
The separation ofthepostlabelednucleotides from
untreated human DNA is shown in Figure 4. The
composition ofeach nucleotide is shown in Table 1.
10 15 20
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FIGURE 2. HPLC separation of 5'-deoxynucleotide: 10 IL
each of 0.5 mg/mL 5'-dCMP, 5'dUMP, 5-methyl 5'-dCMP,
5'-dTMP, 5'-dGMP and 5'-dAMP were injected on the
reverse-phase column. Detection by ultraviolet absorbance
at 260 run.
ELUT/ON TIME, Minutfes
FIGURE 3. HPLC reverse-phase separation of 5'-de-
oxynucleotides from human DNA digested with DNAse
I and snake venom phosphodiesterase. Detection by
ultraviolet absorbance at 260 nm.
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Table 1. Percentages of bases for control DNA and DNA
treated with DMS.
Content of bases, %
Control (no DMS
Base treatment) treatment
5'-dCMP 23.8 29.5
5'-dUMP 1.07 1.70
5'-Me-5'-dCMP 0.57 0.83
5'-dTMP 24.2 28.7
5'-dGMP 22.8 5.52
5'-dDMP 27.0 15.7
DMS products - 18.1
It is noted that the content of 5-methylcytosine is
0.6%, which is comparable to a published value of
0.4% for human DNA (10).
Thetreatment ofhuman DNAwithDMSresulted
in the formation of modified bases, as is evident in
Figure 5. Three new eluting products are seen in
the HPLC separation of the labeled 5'-deoxynu-
cleotides. The three new peaks most likely result
from purine methylation, as the percentage of nor-
mal purine bases is less than in the untreated DNA
(see Table 1). The identification ofeach DMS prod-
uct was not possible, as markers were not available
for 5'-deoxynucleotides containing methylated pur-
ines. However, preliminary evidence from the treat-
ment of5'-dGMP and 5'-dAMP with DMS indicates
that the product which elutes prior to 5'-dTMP
results fromthe methylation ofadenine, as doesthe
product which elutes immediately after 5'-dAMP
(data not shown). The product eluting most distant
from the solvent front may be formed from the
methylation of guanine.
Discussion
A new method has been presented allowing the
detection of infrequent base modifications in DNA
without the use of either radioactive DNA precur-
sors or radiolabeled drugs or mutagens. Given the
high specific activity of y2P-ATP available and the
high resolution ofHPLC reverse-phase chromatog-
raphy, infrequent base modifications in the range of
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one in 105 should be detectable. The method is
also useful for the detection ofmodified nucleotides
which can be incorporated into DNA. Once such
nucleotide is cytosine arabinoside monophosphate
(ara-CMP). Thenucleosidecytosinearabinoside(araC)
is used as an antitumor agent in the treatment of
several kinds of leukemia (11). Once incorporated
into DNA, ara-CMP can be isolated and has been
resolved by HPLC (12). The 3'ara-CMP can be
labeled by the DNA postlabeling method, and the
resulting formation of5'-ara-CMP is shown in Fig-
ure 6. It should also be possible to label other
nucleotide analogs which can be incorporated into
DNA.
Use of the Alphoid Sequence as
an Indicator of DNA Damage
We have also developed an analytical method for
detection ofDNA damage within defined sequences
of human DNA. This method has the advantage
thatitpermitsdetermination ofdistributionofDNA
tL
damage within defined DNA sequences. It also has
the advantage that such damage can be determined
within intact human cells. Thus, cells from individ-
uals that have been exposed to high levels of toxic
substances can be examined at the level ofindivid-
ual nucleotides for DNA damage.
It is unlikely that the use ofthe alphoid sequence
will be suitable forroutine analysis offield samples.
Limit ofdetection ofDNAlesions usingthis method
is about one alteration per thousand nucleotides.
However, the method will serve as an important
tool to determine the types of DNA damage that
are created by noxious chemicals. Forthis analysis,
the chemical composition -ofthe damaging mix need
not be known.
The Method
For this work we used the alphoid sequence of
human DNA (13-16). The alphoid sequence is ideal
for this purpose. It is a highly reiterated sequence
presentin about300,000 copiesperhaploidgenome.
The alphoid sequence is present in tandem arrays
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FIGURE 5. HPLC reverse-phase separation of 32P-labeled 5'-deoxynucleotides from DMS-treated human DNA. Fractions (*) were
collected every 0.3 min and radioactivity was measured by Cerenekov counting.
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FIGURE 6. HPLC reverse-phase separation of 32P-labeled 5'-araCMP. Fractions (*) were collected every 0.5 min and radioactiv-
ity was measured by Cerenekov counting.
up to 40 repeat units in length (15). The basic
repeat length ofthe human alphoid sequence is 342
nucleotides (13). This sequence is itself derived
from an imperfect repeat unit of 171 nucleotides.
The alphoid sequence comprises about 1% of the
total mass of human DNA. For a thorough treat-
ment ofthe structure ofthe humanalphoid sequenc-
es, see the article by Wu and Manuelidis (15).
The alphoid DNA can be readily obtained from
total genomic extracts. The detailed methods of
isolation are presented below. Figures 7 and 8 are
schematic illustrations ofthe isolation and labeling
procedure. Total DNAis prepared fromintact cells.
Anyhuman tissue or cultured cell line may be used,
as the alphoid sequence is present in all normal and
tumor cells. After purification, total cellular DNA
is treated with a restriction enzyme, Eco RI. The
alphoid sequence contains an Eco RI cleavage site.
Treatment with Eco RI releases amajor fraction of
the alphoid DNA as a fragment of 342 nucleotide
length as a direct consequence ofthe tandem array
organization ofthe alphoid DNA. This 342base pair
fragment is easily separated from the bulk of the
cellular DNA that is cleaved into fragments of
between 3000 and 6000 base pairs (Fig. 9). For the
analysis, the Eco RI alphoid fragment canbelabeled
at eitherthe 3' or 5' terminus. DNAfragments that
contain a single labeled terminus are obtained by
treatment of the Eco RI fragment with restriction
enzymesthatcleavethe DNA. Arestrictionenzyme
cleavage map of the Eco RI alphoid DNA is pic-
tured in Figure 10. We have used both the Eco RI*
of92base pairlength and the Mbo I fragments of52
base pair length for our work.
Ifthe human alphoid sequence is to be useful for
these studies, it must have a defined sequence.
Fortunately this isthe case forboththe Eco RI/Eco
RI* and the Eco RI/Mbo I alphoid fragments. Fig-
ure 11 depicts the products of the Maxam-Gilbert
sequencingreactions (17) applied tothe Eco RI/Eco
RI* 92 base pair fragment. It is evident that a
single, unambiguous sequence can be deduced from
this gel. The sequence of the Eco RI fragment as
reported by Manuelidis et al. (13, 15) and confirmed
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FIGURE 7. Schematic diagram of the DNA extraction pro-
cedure. Total cellular DNA is extracted from cells and
then digested with the restriction endonuclease Eco RI
yielding the highly reiterated 342 base pair alphoid
sequence.
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FIGURE 8. Schematic diagram of the labeling procedure
and subsequent digestion with Eco RI*. The 342 base
pair fragment is labeled with either (a-32P) dATP and
(a-3P)dTTP or with (Y-3mP)dATP and then cut with
restriction endonuclease Eco RI*, yielding a 92 base pair
fragment labeled at one terminus.
in part by our work is shown in Figures 10 and 11.
The alphoid sequence ofhuman DNA can be used
as anindicator to compare DNAdamage inflicted in
vitro to damage created upon treatment ofthe same
agent in vivo. We have used this procedure to
studyDNAdamageinbothsituationscreatedeither
by ultraviolet light (18) orby nitrogen mustard (9).
The example ofultraviolet light damage taken from
our previous work (18) is given below. Any human
tissue or human cell in culture can be used for
preparation ofthe alphoid sequence. We have used
FIGURE 9. Human DNA digested with the restriction
endonuclease Eco RI run on a 5% acrylamide gel stained
with ethidium bromide. This gel illustrates the highly
reiterated 342 and 680 base pair tandem repeats.
a number ofcell lines including the HeLa cells, the
TK6 line ofhuman B lymphoblasts (8) and the CEM
human lymphoblastic leukemia cell line (19). We
have also used normal and transformed human
fibroblasts grown in cell culture.
DNA Purification
Thefirststepoftheprocedureinvolvespurification
of the cellular DNA. For this work the starting
cells should be washed free of culture medium.
Then 1 x 106 cells/mL in 100 mL grown in suspen-
sion are pelleted and washed in phosphate buffered
saline. The pellet is resuspended in SSC (0.15M
NaCl/0.015 sodium citrate). Sodium dodecyl sulfate
(SDS) is added to a final concentration of 1%. Pro-
teinase K (2.5 mg/mL, predigested for 30 min at
37°C) is added to aconcentration of0.01 mg/mL and
is incubated for 30 min at 50°C. Proteinase K is
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DdeI 20 30 40 50
AATTCTCAFG AACTTCCTTG ATTCAACTCA CAGAGTTGAA
TTAAGAGTCA TTGAAGGAAC ACAACACACA TAAGTTGAGT GTCTCAACTT
MboI 60 70
CGATCCTTTA CACAGAGCAG Al
GCTAGGAAAT GTGTCTCGTC I
110 Fnu4HI
AGTGGAGATT TCAGCCGCTT Ti
TCACCTCTAA AGTCGGCGAA A
160 170
CCTATAGAAA CTAGACAGAA
GGATATCTTT GATCTGTCTT
FIGURE 10. The 171 base pair sequence of human alphoid
listed above the recognition sequence.
FIGURE 11. Products of the Maxam and Gilbert sequencing
reactions. The 92 base pair 3' auP-labeled alphoid sequence
is treated for sequence analysis: (lane 1) control, no
treatment; (lane 2) treated with hydrazine in the pres-
ence of NaCl for analysis of C; (lane 3) treated with
hydrazine for analysis of C+T; (lane 4) treated with DMS
(dimethyl sulfate) for analysis of G; (lane 5) treated with
piperidine formate for analysis of G +A.
80 90 EcoRi*100
LCTTGAAACA CTCTTTTTGT GGAATTTGCA
rGAACITTGT GAGAAAAACA CCTTAAACGT
130 140 MboII
PGAGGTCAAT GGTAGAATAG GAAATATCTT
kCTCCAGTTA CCATCTTATC CTTTATAGAA
HinFI
TGATTC
ACTAAG
DNA. The restriction endonucleases which digest this sequence are
added again to the same concentration and incu-
bated for an additional 30 min at 50°C. This mix-
ture is then extracted two times with phenol (redis-
tilled) thathasbeensaturatedwithSSCandextracted
two additional times with a mixture ofchlorophorm
andisoamyl alcohol (19:1, vol/vol). The nucleic acids
are precipitated by addition oftwo volumes ofcold
95% ethanol. The DNA is collected by spooling on a
glass rod. The precipitate is resuspended in 2 mL of
SSC, and ribonuclease A (2 mg/mL) is added to a
final concentration of 0.04 mg/mL. The mixture is
incubated at 37°C for 30 min. Proteinase K (2.5
mg/mL) is added to a concentration of0.025 mg/mL
and incubated at 37°C for 30 min. The mixture is
then brought to a final volume ofbetween 10 and 15
mL with SSC and extracted two times with phenol
and two additional times with the chlorophorm
isoamyl alcohol mix indicated above. The DNA is
precipitated with 2 volumes of 95% ethanol and
spooled. The DNA is then lyophilized.
Eco RI Restriction Enzyme Cleavage
of Human DNA.
The lyophilized DNA is resuspended in the Eco
RI cleavagebuffer(100mMTris-HCI, pH 7.5; 50mM
NaCl; 5mM MgC92; 100 ,ug/mL bovine serum albu-
min) and is digested with the restriction enzyme,
Eco RI, at a concentration of3 units ofenzyme to 1
,ug of DNA at 37°C for 3 hr. Sodium ethylene-
diaminetetraacetic acid (EDTA) was added to a
final concentration of25mM to terminate the reac-
tion.
To isolate the alphoid DNA from the bulk ofthe
cellular DNA, the Eco RI digest is centrifuged
through a4.6mL 15-30% sucrose gradient at50,000
rpm in a Beckman VTi-65 rotor for 90 min at 20°C.
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The buffer for the sucrose gradient is 1X Agarose
buffer (see below). The gradient is fractionated,
and 20 ,uL of each fraction is analyzed on a 2%
agarose gel containing ethidium bromide (0.003
mg/mL). The agarose gel contains 3 g ofagarose in
150 mL. The gel buffer is 0.04M Tris-HCl, pH 8.0;
0.018 M NaCI, 0.02M EDTA. The fractions con-
taining the 342 base pair alphoid sequence are
located by visualization of the ethidium bromide
stained bands using shortwave ultraviolet light.
The gel is photographed with a Polaroid MP-3
industrial camera and type 57 (4 x 5) Land film.
There should be a discrete band visible in the
fractions containing the 342 base pair fragment.
These fractions are then pooled and precipitated
with ethanol. The precipitate is lyophilized and
stored in lOmM Tris-HCl, pH 8.0, lmM EDTA at
-20°C. An alternative to visualization ofthe alphoid
sequence using ethidiumbromide stained gels is the
inclusion of a labeled restriction fragment of suit-
able length in the sucrose gradient.
Terminal Labeling of the Alphoid
342 Base Pair Fragment
The 3'-termini can be labeled in reactions that
contain the Klenow fragment of DNA polymerase
(11 units), and 30 puCi each of (ao-32P)dATP and
(a-32P)dTTP, 7mM Tris-HCl, pH 7.5, 7mM MgCl2,
50mM NaCl, O.lmM DTT, 0.01mM dGTP, 0.01mM
dCTP and that are incubated for 50 min at 10°C.
Following this incubation, 0.01mM dATP and
O.OmM dTTP (unlabeled) are added, and the reac-
tion mixture is incubated for an additional 10 min at
10°C (20). The DNA is then precipitated by addi-
tion of sodium acetate to a final concentration of
0.3M, 10 ,ug of the tRNA and two volumes of 95%
ethanol. The mixture is chilled to -70°C in a dry
ice-ethanol bath for 15 min. The mixture is then
centrifuged at 15,000g in an Eppendorf centrifuge
for 15 min. The supernatant is discarded and the
pellet is washed with 95% ethanol and then lyophi-
lized.
For labeling ofthe 5' terminus the DNA is incu-
bated in areaction containing lOOmMimidizole, pH
6.6, 20mM MgC92, 8mM DTT, 0.2mM spermine,
0.2mM EDTA, 0.6mMADP, 16mMMgC92, and 1.5
units of polynucleotide kinase. The reaction also
includes 250 ,uCi of (y-32P)dATP that has been
lyophilized in the tube prior to addition ofthe other
reaction components. The reaction mixture is incu-
bated at 37°C for 60 min. The labeled DNA is
precipitated by the addition of ammonium acetate
to a final concentration of 0.3M and 2 volumes of
95% ethanol.
Isolation of the 92 Base Pair
End-Labeled Eco RI/Eco RI* Fragment
of Alphoid DNA
The alphoid DNAwhichis labeled atbothtermini
is then digested with another restriction enzyme to
obtain fragments that are labeled at a single termi-
nus. To obtain a 92 base pair alphoid fragment
derived by cleavage of the 342 base pair fragment
with Eco RI*, the labeled DNA is resuspended in
the Eco RI* reaction buffer which contains 25mM
Tris-HCI, pH 8.6, 2mM MgCl2, and 20% glycerol
(21). The reaction is incubated for 1 hr at 37°C with
70 units ofEco RI. A mixture oftwo dyes, bromo-
phenol blue and xylene cyanol, both at a concentra-
tion of 0.05%, is added to the reaction mix. This
preparation is layered directly onto a polyacryl-
amide gel for separation of the cleaved fragments.
For isolation of the 92 base pair fragment, the
cleaved DNA is layered onto a 5% polyacrylamide
gel made with TEB buffer (50mM Tris-HCl, 50mM
boric acid, lmM EDTA). The gel is polymerized
with 0.07% ammonium persulfate and TEMED
(N,N,N'N'-tetramethylethylenediamine). The gel
is run at 400 V until the slow-moving dye has
migrated halfway down a 40 cm long gel. In order
toisolate thegelfragment, the92basepairsequence
is located by autoradiography and the fragment
excised from the gel. DNA is removed from the gel
fragmentbycrushingthegelpiecewithasiliconized
glass rod in a 1.5 mL Eppendorftube. A solution of
0.3M sodium acetate is added to the crushed gel
and the mixture is rotated overnight at room tem-
perature. The gel mixture is spun for 3 min in an
Eppendorfcentrifuge, andthesupernatantisremoved
and saved. The crushed gel is washed with 0.3M
sodium acetate twice until most ofthe radioactivity
has been eluted from the crushed gel. The superna-
tants are pooled and filtered through a 0.45 pum
cellulose acetate filter. The DNA is precipitated by
an addition oftwo volumes of 95% ethanol. The 92
base pair fragment is then ready for use.
Results
The alphoid sequence can be used to compare
DNA damage created by treatment of DNA in
vitrotodamagedepositedinthesame DNAsequence
when that sequence is part ofthe intact cells (Fig.
12). An experiment of this type is described using
ultraviolet light as the insulting agent.
The 3' end-labeled 92 base pair Eco RI/Eco RI*
alphoid sequence was prepared from cellsthatwere
either untreated or treated with 5000 J/m2 of 254
nanometer light from a germicidal lamp. A fraction
ofthe DNA extracted from the untreated cells was
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FIGURE 12. Comparison of ultraviolet-induced damage to
cellular DNA and purified DNA: (lanes 1-4) no irradia-
tion; (lanes 5-8) irradiation of purified DNA at 5000 J/m2;
(lane 9) NCS sequencing rx; (lanes 10-13) irradiation of
intact cells at 5000 J/m2; (lanes 1, 5, 10) control, no
treatment; (lanes 2, 6, 11) treated with M. luteus pyrim-
idine dimer endonuclease; (lanes 3, 7, 12) treated with
1M piperidine at 90°C for 20 min; (lanes 4, 8, 13) treated
with M. luteus pyrimidine dimer endonuclease followed
by treatment with 1M piperidine at 90°C for 20 min. The
92 bp fragment was prepared as described and layered
on a 8% polyacrylamide urea containing sequencing gel
(17).
also treated with 5000 J/m2 from the same source.
These three samples were analyzed on a polyacryl-
amide gel after (1) no treatment, (2) treatment with
a preparation of the ultraviolet-specific endonucle-
ase purified from M. luteus that cleaves the DNA
at sites of cyclobutane pyrimidine dimers or (3)
treatment with 1M piperidine for 20 min at 90°C [a
treatment that cleaves the DNA at PyC lesions
(18)] and treatment with the M. luteus enzyme
followedbytreatment with 1Mpiperidine asbefore.
The results ofsuch an experiment are illustrated
in Figure 12. The alphoid DNA extracted from
untreated cells is not broken by any of the treat-
ments. Treatment of ultraviolet-irradiated alphoid
DNA with piperidine or ultraviolet-specific endo-
nuclease creates strand breaks atspecific sites which
are evident as DNA fragments that migrate more
rapidly than the intact 92-mer. The sites ofdamage
in DNA irradiated in vitro and within intact cells
can be compared by analysis of the cleavage pat-
terns. The relative amount of damage at each site
can be determined by measurement of the amount
of radioactivity in gel slices that correspond to
discrete bands in the autoradiograms. The amount
ofdamage at sixspecific sitesinthe alphoid DNA as
afunction ofincreasingultraviolet dose is plotted in
Figures 13 and 14. These data demonstrate thatthe
sites at which DNA damage occurs are similar in
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FIGURE 13. Dose-response for UV light-induced damage to
human alphoid DNA for (e,An) intact cells and (o,A,rj)
purified DNA. Dose-response of pyrimidine dimer dam-
age was determined by treatment of the irradiated DNA
with the M. luteus pyrimidine dimer-specific endo-
nuclease followed by resolution of the scission products
on urea containing polyacrylamide sequencing gels. Scis-
sion occurred at the sequences indicated by the asterisk
(o,- G-T*-T-G (37'-34'); (/&,A), G-T*-T*-C-A (51'-47');
(oI,n) G-T*-T*-T*-C-A (79'-74'). The positions of the
sequences within the alphoid DNA are indicated by the num-
bers in parentheses. The percentage of scission is the frac-
tion oftheinputmolecules broken atthe sequences indicated.
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FIGURE 14. Dose-response for ultraviolet light-induced
damage to human alphoid DNA for (e,An) intact cells and
(oA,,o) purified DNA. Dose-response for alkali-labile
lesions was determined by treatment of the irradiated
DNA with 1M piperidine at 90°C for 20 min prior to
layering on the gel. The percentage of scission was com-
puted as in Fig. 13. Alkali-induced scission occurred at
the sequences indicated by asterisks: (o,o) A-C-T-C*-T-G
(46'-41'); (A,,) G-T-T-C*-A (51'-47'); (E,m) G-T-T-T-T-C*-A
(79'-74')-
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Table 2. Stability of the ultraviolet light-induced damage.'
UV Strand scission, %
Treatment intensity, J/m2 0 hr 24 hr Siteb
PyrDEase 100 0.66 0.49 A-C-T-C-T-G
0.59 0.75 G-T-T-C-A
0.77 0.73 G-T-T-T-C-A
Piperidine 100 3.79 2.60 A-C-T-C-T-G
1.51 1.22 G-T-T-C-A
PyrDEase and piperidine 100 4.48 4.48 A-C-T-C
3.03 2.50 G-T-T-C-A
4.35 5.78 G-T-T-T-C-A
PyrDEase 1000 0.98 2.40 G-T-T-G
2.35 2.70 A-C-T-C-T-G
2.53 2.70 G-T-T-C-A
4.60 4.43 G-T-T-T-C-A
Piperidine 1000 3.06 2.68 G-T-T-C-A
3.42 3.29 G-T-T-T-C-A
PyrDEase and piperidine 100 7.63 6.81 G-T-T-T-C-A
'CEM cells were irradiated with either 100J/m2 OR 1000J/m2 ofUVlight. DNAwas extracted immediately fromhalfofthe cells and
analyzed forthe distribution ofeither pyrimidine dimers oralkaline-sensitive lesions as described inthe textby treatmentofthe DNA
with either the M. luteus pyrimidine dimer-specific endonuclease (PyrDEase) or with 1M piperidine at 90°C for 20 min or with
PyrDEase followed by piperidine treatment. The remaining cells were resuspended in complete medium and incubated for 24 hr at
37°C prior to extraction ofthe DNA. In both cases the 3' end-labeled 92 base pair a-DNA fragment was prepared, and the amount of
strand scission is shown as percentage of input molecules broken at the sequences indicated.
bThe asterisks indicate the sites of breakage within the sequence. Sequences studied included G-T-T-G (37'-34'), A-C-T-C-T-G
(46'-41'), G-T-T-C-A-(51'-47'), and G-T-T-T-C-A (79'-74'), in which the numbers indicate the position on the 3' end-labeled strand
relative to the labeled Eco RI end.
the two situations. However, the effective dose
seen by the DNA in intact cells is about 50% ofthe
effective dose for the same fragment when it is
irradiated as naked DNA. This is the case over the
entire dose range of 50-5000 J/m2.
This method can alsobe used tojudge the physio-
logical stability of individual DNA lesions. Thus,
the PyC and cyclobutane dimerlesions are stable in
cellular DNA when the cells are exposed to very
high doses, i.e., 5000J/m2 ofultraviolet light (Table
2). It is hoped that this method will be useful for
detection ofintermediates in the DNA repair path-
ways when lower doses ofultraviolet lightare used.
Thismethod is capable ofdetectingdamage induced
bylowultravioletfluences. Wehavedetectedlesions
in alphoid DNA exposed to as little as 15 J/m2 of
ultraviolet light.
Summary
The alphoid DNA provides a convenient tool for
the analysis of DNA damage within intact cells at
thelevelofindividualnucleotidesequences. Itshould
provide a sensitive tool for the study of DNA.
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